PCM
SHC icon

Prelude Capital Management’s Sotera Health SHC Stock Holding History

Prelude Capital Management’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Buy
208,430
+99,822
+92% +$1.57M 0.27% 90
2026
Q1 		$1.56M Buy
108,608
+85,756
+375% +$1.42M 0.12% 208
2025
Q4 		$403K Buy
22,852
+12,792
+127% +$212K 0.03% 630
2025
Q3 		$158K Buy
+10,060
New +$141K 0.01% 994
2025
Q1 		– Sell
-11,080
Closed -$152K – 1482
2024
Q4 		$152K Sell
11,080
-19,950
-64% -$289K 0.01% 1047
2024
Q3 		$518K Buy
31,030
+10,685
+53% +$156K 0.03% 615
2024
Q2 		$241K Sell
20,345
-2,511
-11% -$28.7K 0.02% 901
2024
Q1 		$275K Buy
+22,856
New +$340K 0.01% 941
2023
Q1 		– Sell
-47,662
Closed -$397K – 1439
2022
Q4 		$397K Buy
+47,662
New +$356K 0.02% 666
2022
Q1 		– Sell
-39,654
Closed -$934K – 2176
2021
Q4 		$934K Sell
39,654
-47,729
-55% -$1.14M 0.02% 651
2021
Q3 		$2.29M Buy
87,383
+1,433
+2% +$34.7K 0.06% 263
2021
Q2 		$2.08M Sell
85,950
-5,560
-6% -$137K 0.06% 286
2021
Q1 		$2.28M Buy
+91,510
New +$2.42M 0.06% 298

Other funds holding SHC

SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

Prelude Capital Management's SHC Position: Q2 2026 in Review

Prelude Capital Management increased its Sotera Health (SHC) stake by 92% in Q2 2026, buying an estimated $1.57M and bringing the position to 208,430 shares worth $3.7M. The position accounts for 0.27% of the portfolio, ranked #90.

Prelude Capital Management first reported a position in SHC in Q1 2021 and has held it in 13 quarters since. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Prelude Capital Management held 208,430 shares of Sotera Health worth $3.7M as of Q2 2026.
  • Prelude Capital Management bought 99,822 Sotera Health shares in Q2 2026, an estimated $1.57M.
  • Sotera Health made up 0.27% of Prelude Capital Management's portfolio in Q2 2026, its #90 holding.
  • Prelude Capital Management first reported a position in Sotera Health in Q1 2021 and has held it in 13 quarters since.
  • 320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.